(FGEN)


Exchange


Currency in (Disclaimer)
Volume:
Day's Range:

FGEN Insider Transactions

Transaction Date
(SEC Report )
Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price() Amount()
2023-03-23 Wettig Thane officer: Chief Commercial Officer 110,653 S-Sale D 905 18.71 16,932.55
2023-03-10 Conterno Enrique A director, officer: Chief Executive Officer 384,868 S-Sale D 19,489 20.20 393,625.18
2023-03-10 Chung Christine officer: SVP, China Operations 259,050 S-Sale D 2,914 20.20 58,854.93
2023-03-10 Chung Christine officer: SVP, China Operations 261,964 S-Sale D 4,692 20.20 94,765.73
2023-03-10 Conterno Enrique A director, officer: Chief Executive Officer 404,357 S-Sale D 12,103 20.20 244,447.92
2023-03-10 Wettig Thane officer: Chief Commercial Officer 111,558 S-Sale D 4,731 20.20 95,553.43
2023-03-10 Wettig Thane officer: Chief Commercial Officer 116,289 S-Sale D 2,938 20.20 59,339.67
2023-03-10 Graham Juan officer: Chief Financial Officer 72,868 S-Sale D 2,344 20.20 47,342.47
2023-03-10 Graham Juan officer: Chief Financial Officer 75,212 S-Sale D 1,456 20.20 29,407.27
2023-03-10 Graham Juan officer: Chief Financial Officer 76,668 S-Sale D 1,112 20.20 22,459.40
2023-03-10 Eisner Mark officer: Chief Medical Officer 175,176 S-Sale D 6,255 20.20 126,334.11
2023-03-10 Eisner Mark officer: Chief Medical Officer 181,431 S-Sale D 3,885 20.20 78,466.51
2023-03-08 Chung Christine officer: SVP, China Operations 266,656 A-Award A 9,338 0.00 0.00
2023-03-08 Chung Christine officer: SVP, China Operations 257,318 A-Award A 5,799 0.00 0.00
2023-03-08 Chung Christine officer: SVP, China Operations 251,519 S-Sale D 8,354 21.16 176,736.39
2023-03-08 Conterno Enrique A director, officer: Chief Executive Officer 416,460 A-Award A 37,229 0.00 0.00
2023-03-08 Conterno Enrique A director, officer: Chief Executive Officer 379,231 A-Award A 23,120 0.00 0.00
2023-03-08 Conterno Enrique A director, officer: Chief Executive Officer 356,111 S-Sale D 24,672 21.16 521,958.36
2023-03-08 Wettig Thane officer: Chief Commercial Officer 119,227 A-Award A 9,338 0.00 0.00
2023-03-08 Wettig Thane officer: Chief Commercial Officer 109,889 A-Award A 5,799 0.00 0.00
2023-03-08 Wettig Thane officer: Chief Commercial Officer 104,090 S-Sale D 6,265 21.16 132,541.71
2023-03-08 Graham Juan officer: Chief Financial Officer 77,780 A-Award A 4,668 0.00 0.00
2023-03-08 Graham Juan officer: Chief Financial Officer 73,112 A-Award A 2,899 0.00 0.00
2023-03-08 Graham Juan officer: Chief Financial Officer 70,213 S-Sale D 2,749 21.16 58,157.57
2023-03-08 Eisner Mark officer: Chief Medical Officer 185,316 A-Award A 12,451 0.00 0.00
2023-03-08 Eisner Mark officer: Chief Medical Officer 172,865 A-Award A 7,732 0.00 0.00
2023-03-08 Eisner Mark officer: Chief Medical Officer 165,133 S-Sale D 7,363 21.16 155,770.89
2023-03-02 Eisner Mark officer: Chief Medical Officer 172,496 S-Sale D 1,187 21.87 25,959.69
2023-02-21 Graham Juan officer: Chief Financial Officer 42,000 A-Award A 42,000 22.60 949,200.00
2023-02-21 Graham Juan officer: Chief Financial Officer 72,962 A-Award A 25,000 0.00 0.00
2023-02-21 Wettig Thane officer: Chief Commercial Officer 42,000 A-Award A 42,000 22.60 949,200.00
2023-02-21 Wettig Thane officer: Chief Commercial Officer 110,355 A-Award A 25,000 0.00 0.00
2023-02-21 Eisner Mark officer: Chief Medical Officer 55,000 A-Award A 55,000 22.60 1,243,000.00
2023-02-21 Eisner Mark officer: Chief Medical Officer 173,683 A-Award A 32,500 0.00 0.00
2023-02-21 Chung Christine officer: SVP, China Operations 42,000 A-Award A 42,000 22.60 949,200.00
2023-02-21 Chung Christine officer: SVP, China Operations 259,873 A-Award A 25,000 0.00 0.00
2023-02-21 Conterno Enrique A director, officer: Chief Executive Officer 143,100 A-Award A 143,100 22.60 3,234,060.00
2023-02-21 Conterno Enrique A director, officer: Chief Executive Officer 380,783 A-Award A 85,300 0.00 0.00
2023-01-06 Conterno Enrique A director, officer: Chief Executive Officer 295,483 S-Sale D 1,538 19.95 30,683.10
2022-12-23 Wettig Thane officer: Chief Commercial Officer 89,163 S-Sale D 734 15.80 11,597.20
2022-12-12 Graham Juan officer: Chief Financial Officer 47,962 S-Sale D 1,407 14.50 20,401.50
2022-12-12 Graham Juan officer: Chief Financial Officer 53,703 S-Sale D 1,407 14.50 20,401.50
2022-12-09 Graham Juan officer: Chief Financial Officer 49,369 S-Sale D 781 14.89 11,629.09
2022-12-09 Graham Juan officer: Chief Financial Officer 55,110 S-Sale D 781 14.90 11,636.90
2022-12-08 Chung Christine officer: SVP, China Operations 234,873 S-Sale D 2,595 15.79 40,975.05
2022-12-08 Graham Juan officer: Chief Financial Officer 50,150 S-Sale D 478 15.47 7,394.66
2022-12-08 Graham Juan officer: Chief Financial Officer 50,628 S-Sale D 5,263 14.84 78,102.92
2022-12-08 Conterno Enrique A director, officer: Chief Executive Officer 297,020 S-Sale D 2,543 15.79 40,153.97
2022-12-08 Wettig Thane officer: Chief Commercial Officer 89,897 S-Sale D 382 15.79 6,031.78
2022-12-08 Chung Christine officer: SVP, China Operations 237,705 S-Sale D 1,096 15.79 17,305.84
2022-12-01 Eisner Mark officer: Chief Medical Officer 141,183 F-InKind D 1,084 15.04 16,303.36
2022-10-06 Conterno Enrique A director, officer: Chief Executive Officer 299,563 F-InKind D 1,296 14.26 18,480.96
2022-09-30 Chung Christine officer: SVP, China Operations 238,801 F-InKind D 4,683 13.01 60,925.83
2022-09-30 Eisner Mark officer: Chief Medical Officer 142,267 F-InKind D 6,777 13.01 88,168.77
2022-09-22 Wettig Thane officer: Chief Commercial Officer 90,279 F-InKind D 655 12.26 8,030.30
2022-09-07 Graham Juan officer: Chief Financial Officer 55,891 F-InKind D 3,009 12.62 37,973.58
2022-09-06 Chung Christine officer: SVP, China Operations 242,151 F-InKind D 1,851 12.26 22,693.26
2022-09-06 Chung Christine officer: SVP, China Operations 243,484 F-InKind D 518 12.26 6,350.68
2022-09-06 Conterno Enrique A director, officer: Chief Executive Officer 300,859 F-InKind D 1,772 12.26 21,724.72
2022-09-06 Wettig Thane officer: Chief Commercial Officer 90,934 F-InKind D 360 12.26 4,413.60
2022-09-01 Eisner Mark officer: Chief Medical Officer 149,044 F-InKind D 756 13.09 9,896.04
2022-08-22 Wettig Thane officer: Chief Commercial Officer 85,355 G-Gift D 1,820 0.00 0.00
2022-07-06 Conterno Enrique A director, officer: Chief Executive Officer 302,631 F-InKind D 1,296 12.40 16,070.40
2022-06-22 Wettig Thane officer: Chief Commercial Officer 91,294 F-InKind D 655 11.42 7,480.10
2022-06-16 Henderson Jeffrey William director 25,684 A-Award A 25,684 9.00 231,156.00
2022-06-16 Henderson Jeffrey William director 33,577 A-Award A 15,777 0.00 0.00
2022-06-16 Ho Maykin director 25,684 A-Award A 25,684 9.00 231,156.00
2022-06-16 Ho Maykin director 31,732 A-Award A 15,777 0.00 0.00
2022-06-16 EDWARDS JEFFREY L director 25,684 A-Award A 25,684 9.00 231,156.00
2022-06-16 EDWARDS JEFFREY L director 33,577 A-Award A 15,777 0.00 0.00
2022-06-16 Cravatt Benjamin director 25,684 A-Award A 25,684 9.00 231,156.00
2022-06-16 Cravatt Benjamin director 24,391 A-Award A 15,777 0.00 0.00
2022-06-16 Brennan Aoife director 25,684 A-Award A 25,684 9.00 231,156.00
2022-06-16 Brennan Aoife director 24,391 A-Award A 15,777 0.00 0.00
2022-06-16 Lema Gerald director 25,684 A-Award A 25,684 9.00 231,156.00
2022-06-16 Lema Gerald director 20,477 A-Award A 15,777 0.00 0.00
2022-06-16 Blaug Suzanne director 25,684 A-Award A 25,684 9.00 231,156.00
2022-06-16 Blaug Suzanne director 29,825 A-Award A 15,777 0.00 0.00
2022-06-16 Schoeneck James A director 25,684 A-Award A 25,684 9.00 231,156.00
2022-06-16 Schoeneck James A director 20,477 A-Award A 15,777 0.00 0.00
2022-06-06 Chung Christine officer: SVP, China Operations 244,002 F-InKind D 1,850 9.50 17,575.00
2022-06-06 Wettig Thane officer: Chief Commercial Officer 89,961 F-InKind D 360 9.50 3,420.00
2022-06-06 Conterno Enrique A director, officer: Chief Executive Officer 301,940 F-InKind D 1,772 9.50 16,834.00
2022-06-01 Eisner Mark officer: Chief Medical Officer 149,800 F-InKind D 1,141 9.61 10,965.01
2022-05-25 Wettig Thane officer: Chief Commercial Officer 87,175 G-Gift D 1,988 0.00 0.00
2022-04-07 Conterno Enrique A director, officer: Chief Executive Officer 303,712 F-InKind D 1,311 12.73 16,689.03
2022-03-31 Eisner Mark officer: Chief Medical Officer 150,941 F-InKind D 6,442 12.02 77,432.84
2022-03-31 Chung Christine officer: SVP, China Operations 245,852 F-InKind D 4,682 12.02 56,277.64
2022-03-22 Wettig Thane officer: Chief Commercial Officer 90,321 F-InKind D 655 13.31 8,718.05
2022-03-07 Wettig Thane officer: Chief Commercial Officer 90,976 F-InKind D 1,706 12.69 21,649.14
2022-03-07 Conterno Enrique A director, officer: Chief Executive Officer 305,023 F-InKind D 7,081 12.69 89,857.89
2022-03-07 Chung Christine officer: SVP, China Operations 250,534 F-InKind D 3,905 12.69 49,554.45
2022-03-01 Eisner Mark officer: Chief Medical Officer 157,383 F-InKind D 756 13.62 10,296.72
2022-02-14 Graham Juan officer: Chief Financial Officer 37,500 A-Award A 37,500 15.60 585,000.00
2022-02-14 Graham Juan officer: Chief Financial Officer 58,900 A-Award A 22,500 0.00 0.00
2022-02-14 Wettig Thane officer: Chief Commercial Officer 75,000 A-Award A 75,000 15.60 1,170,000.00
2022-02-14 Wettig Thane officer: Chief Commercial Officer 92,682 A-Award A 45,000 0.00 0.00
2022-02-14 Eisner Mark officer: Chief Medical Officer 100,000 A-Award A 100,000 15.60 1,560,000.00
2022-02-14 Eisner Mark officer: Chief Medical Officer 158,139 A-Award A 60,000 0.00 0.00
2022-02-14 Conterno Enrique A director, officer: Chief Executive Officer 298,000 A-Award A 298,000 15.60 4,648,800.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.